Please use this identifier to cite or link to this item:
Title: Body mass index and disease activity in chronic inflammatory rheumatic diseases: results of the Cardiovascular in Rheumatology (Carma) Project
Author: Valero-Jaimes, Jesús A.
López-González, Ruth
Martín-Martínez, María A.
García-Gómez, Carmen
Sánchez-Alonso, Fernando
Sánchez-Costa, Jesús T.
González Juanatey, Carlos
Revuelta-Evrad, Eva
Díaz-Torné, César
Fernández-Espartero, Cruz
Pérez-García, Carolina
Torrente Segarra, Vicenç
Sánchez-Nievas, Ginés
Pérez-Sandoval, Trinidad
Font-Ugalde, Pilar
García-Vivar, María Luz
Aurrecoechea, Elena
Maiz-Alonso, Olga
Valls-García, Ramón
Miranda-Filloy, José A.
Llorca Díaz, Javier
Castañeda, Santos
González-Gay, Miguel A.
CARMA Study Group
Nolla Solé, Joan Miquel
Keywords: Reumatisme
Issue Date: Jan-2021
Publisher: MDPI
Abstract: Objective: Since obesity has been associated with a higher inflammatory burden and worse response to therapy in patients with chronic inflammatory rheumatic diseases (CIRD), we aimed to confirm the potential association between body mass index (BMI) and disease activity in a large series of patients with CIRDs included in the Spanish CARdiovascular in rheuMAtology (CARMA) registry. Methods: Baseline data analysis of patients included from the CARMA project, a 10-year prospective study of patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) attending outpatient rheumatology clinics from 67 Spanish hospitals. Obesity was defined when BMI (kg/m2) was >30 according to the WHO criteria. Scores used to evaluate disease activity were Disease Activity Score of 28 joints (DAS28) in RA, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in AS, and modified DAS for PsA. Results: Data from 2234 patients (775 RA, 738 AS, and 721 PsA) were assessed. The mean ± SD BMI at the baseline visit were: 26.9 ± 4.8 in RA, 27.4 ± 4.4 in AS, and 28.2 ± 4.7 in PsA. A positive association between BMI and disease activity in patients with RA (β = 0.029; 95%CI (0.01- 0.05); p = 0.007) and PsA (β = 0.036; 95%CI (0.015-0.058); p = 0.001) but not in those with AS (β = 0.001; 95%CI (-0.03-0.03); p = 0.926) was found. Disease activity was associated with female sex and rheumatoid factor in RA and with Psoriasis Area Severity Index and enthesitis in PsA. Conclusions: BMI is associated with disease activity in RA and PsA, but not in AS. Given that obesity is a potentially modifiable factor, adequate control of body weight can improve the outcome of patients with CIRD and, therefore, weight control should be included in the management strategy of these patients.
Note: Reproducció del document publicat a:
It is part of: Journal of Clinical Medicine, 2021, vol. 10, num. 3, p. 382
Related resource:
ISSN: 2077-0383
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
729312.pdf295.51 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons